Colchicine

Colchicine is a plant alkaloid obtained mainly from the autumn crocus, Colchicum autumnale, a flowering plant also known as meadow saffron ^[1]. It is classed as an anti-inflammatory agent and, in the context of gout, as a gout suppressant ^[1]. The whole plant is poisonous, and colchicine itself is a potent toxin at higher exposures, which is why the drug has a famously narrow margin between a helpful and a harmful amount ^[1].

Preparations of Colchicum have been used medicinally for joint swelling since ancient times, with references reaching back thousands of years ^[1]. The active compound was isolated in 1820 by the French chemists Pierre-Joseph Pelletier and Joseph Bienaime Caventou, and it was later purified and named colchicine ^[1]. In the modern era it became an established prescription medicine, sold under brand names such as Colcrys, and it remains inexpensive and widely available ^[1].

The classic use of colchicine is in gout, where it relieves the intense inflammation of an acute flare and, taken regularly, helps prevent flares from recurring ^[1][2]. It is a mainstay treatment for familial Mediterranean fever, an inherited inflammatory disorder, in which long-term use reduces the frequency of attacks and lowers the risk of a serious complication called amyloidosis ^[1]. It is also standard therapy for pericarditis, the inflammation of the sac around the heart, and is used in Behcet disease ^[1][3]. A newer and much-studied application is in cardiovascular disease: because inflammation contributes to atherosclerosis, low-dose colchicine has been tested for preventing heart attacks and strokes, and a large trial in people with chronic coronary disease found that it reduced cardiovascular events, which led to regulatory approval of a low-dose product for this purpose ^[3][4].

Colchicine's usefulness is limited by its toxicity ^[1]. The most common side effects involve the digestive system, especially diarrhoea, nausea and abdominal pain, and these often appear as the first sign that a dose is too high ^[1][2]. In overdose, whether accidental or deliberate, colchicine can cause a delayed but catastrophic illness that progresses from severe gastrointestinal upset to bone marrow suppression, muscle breakdown and failure of multiple organs, and there is no specific antidote, so poisoning is a genuine medical emergency ^[1]. Its levels in the body can also rise dangerously when it is combined with certain other drugs that interfere with its breakdown or clearance ^[1].

Colchicine is a prescription-only medicine, usually taken as tablets, and is listed on the World Health Organization Model List of Essential Medicines ^[1]. It is generally used at low doses, reflecting both its effectiveness at modest amounts and the need to stay well below toxic exposures ^[1][2].

This is a Serious Drug. Diarrhea and GI upset are common even at therapeutic doses, and overdose can cause multi-organ failure and be fatal. It interacts dangerously with CYP3A4 and P-glycoprotein inhibitors like clarithromycin and some statins. Dose must be reduced in kidney or liver impairment and it should only be used under medical supervision.

Colchicine has a narrow margin between a therapeutic and a toxic dose, and it is a substrate of both CYP3A4 and P-glycoprotein, which makes its interactions genuinely dangerous rather than merely inconvenient. Clarithromycin, erythromycin, ketoconazole, itraconazole, ritonavir and most other protease inhibitors, cyclosporine, verapamil and diltiazem block one or both routes. Colchicine then accumulates, and reported outcomes include pancytopenia, agranulocytosis, rhabdomyolysis, multiorgan failure and death, sometimes at ordinary gout doses. The combination is contraindicated outright when kidney or liver function is impaired, since clearance is already reduced there.

Statins and fibrates carry their own myotoxicity, and colchicine compounds it; muscle pain with a rising creatine kinase in someone taking both deserves attention rather than reassurance. Grapefruit juice inhibits intestinal CYP3A4 and belongs on the same list, if lower down it.

Checking a whole stack? Run it through interactions + stacks.

Colchicine is one of the oldest remedies in continuous use; extracts of the autumn crocus (Colchicum autumnale) were described for joint pain in the Ebers Papyrus of ancient Egypt and later recommended by Byzantine physicians for acute gout. The pure alkaloid was first isolated in 1820 by the French chemists Pierre-Joseph Pelletier and Joseph Bienaime Caventou, the same pair who separated quinine and strychnine. Its full chemical structure was not settled until the mid twentieth century, and its mechanism as a tubulin binder that halts microtubule assembly was clarified through cell biology research in the 1960s and beyond.

In the United States colchicine had been marketed for generations before the modern regulatory era; the FDA granted formal approval to a single-ingredient product (Colcrys) for gout and familial Mediterranean fever in 2009. More recently, large cardiovascular outcome trials extended its role into atherosclerotic heart disease, and low-dose colchicine received an FDA indication to reduce cardiovascular risk in 2023.

Colchicine enjoys a distinctive reputation as an ancient plant medicine that has earned a firm place in modern evidence-based practice. It is prized for rapidly quieting the intense pain of an acute gout flare and for preventing the recurrent fevers of familial Mediterranean fever, and it is a mainstay for pericarditis. Its inclusion on the World Health Organization's list of essential medicines reflects both its usefulness and its very low cost.

Interest surged when randomized trials suggested that low daily doses can lower the risk of heart attacks and strokes in people with established coronary disease, positioning this old alkaloid at the frontier of anti-inflammatory cardiology. Clinicians nonetheless respect its narrow therapeutic window, since the same anti-microtubule action that helps at proper doses becomes dangerous in overdose, so careful dosing and attention to drug interactions are essential.